| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | EVP, Chief R&D Officer | Common Stock | 43.5K | $2.36M | $54.16 | Sep 30, 2025 | Direct |
| BIOMARIN PHARMACEUTICAL INC | EVP, Chief R&D Officer | Stock Option (Right to Buy Common Stock) | 41.2K | Mar 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Sep 30, 2025 | 1 | -$179K | 4 | Oct 2, 2025 | EVP, Chief R&D Officer |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 17, 2025 | 2 | $0 | 4 | Mar 18, 2025 | EVP, Chief R&D Officer |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Sep 30, 2024 | 3 | $0 | 4 | Oct 1, 2024 | EVP, Chief R&D Officer |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Sep 30, 2024 | 0 | $0 | 3 | Oct 1, 2024 | EVP, Chief R&D Officer |